Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle.

BACKGROUND Metabolic acidosis in chronic renal failure (CRF) induces loss of lean body mass while elimination of acidosis during a one year trial improved anthropometric indices in continuous ambulatory peritoneal dialysis (CAPD) patients. In rats with CRF, the mechanisms causing loss of lean body mass have been linked to acidosis-induced destruction of the essential, branched-chain amino acids (BCAA) and activation of the ubiquitin-proteasome system that degrades muscle protein; the latter response includes increased transcription of the ubiquitin gene. METHOD Our aim was to determine if increasing the serum bicarbonate (HCO3) concentration of CAPD patients would improve their nutritional status, increase plasma BCAA levels, and reduce ubiquitin mRNA in their muscle as an index of suppressed activity of the ubiquitin-proteasome system. Eight, stable, long-term CAPD patients underwent vastus lateralis muscle biopsy before being randomized to continue 35 mmol/L lactate dialysate or convert to a 40 mmol/L lactate dialysate. After four weeks, measurements were repeated. RESULTS Serum HCO3 increased in all patients and final values did not differ statistically between the two groups so results for all patients were combined. Weight and body mass index increased significantly as did plasma BCAA. Muscle levels of ubiquitin mRNA decreased significantly; serum tumor necrosis factor-alpha (TNF-alpha) also decreased. CONCLUSION Our results indicate that even a small correction of serum HCO3 improves nutritional status, and provide evidence for down-regulation of BCAA degradation and muscle proteolysis via the ubiquitin-proteasome system. Whether acidosis and inflammatory cytokines (such as, TNF-alpha) interact to impair nutrition is unknown.

[1]  G. Biolo,et al.  Mechanisms of malnutrition in uremia. , 1997, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[2]  C. Ronco,et al.  Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. , 2001, Kidney international.

[3]  R. Bellantone,et al.  Increased muscle ubiquitin mRNA levels in gastric cancer patients. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  W. Mitch,et al.  Transcription factors and muscle cachexia: is there a therapeutic target? , 2001, The Lancet.

[5]  J. Kopple,et al.  Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. , 2000, Kidney international.

[6]  W. Mitch,et al.  Glucocorticoids Induce Proteasome C3 Subunit Expression in L6 Muscle Cells by Opposing the Suppression of Its Transcription by NF-κB* , 2000, The Journal of Biological Chemistry.

[7]  G. Biolo,et al.  Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients. , 2000, Metabolism: clinical and experimental.

[8]  B. Piraino,et al.  Pattern of noncompliance with dialysis exchanges in peritoneal dialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  C. Pollock,et al.  Nutritional aspects of peritoneal dialysis , 2000 .

[10]  W. Mitch,et al.  Nutrition and chronic renal failure in rats: what is an optimal dietary protein? , 1999, Journal of the American Society of Nephrology : JASN.

[11]  Claudine Jurkovitz,et al.  Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. , 1999, American journal of physiology. Cell physiology.

[12]  G. Kaysen Biological basis of hypoalbuminemia in ESRD. , 1998, Journal of the American Society of Nephrology : JASN.

[13]  B. Lindholm,et al.  Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. , 1998, Kidney international.

[14]  J. Walls,et al.  Role of an improvement in acid-base status and nutrition in CAPD patients. , 1997, Kidney international.

[15]  S. Downie,et al.  Correction of acidosis in hemodialysis decreases whole-body protein degradation. , 1997, Journal of the American Society of Nephrology : JASN.

[16]  T. Meyer,et al.  Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. , 1997, The Journal of clinical investigation.

[17]  F. Manz,et al.  Alkali therapy versus sodium chloride supplement in low birthweight infants with incipient late metabolic acidosis , 1997, Acta paediatrica.

[18]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[19]  L. Phillips,et al.  Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. , 1996, The Journal of clinical investigation.

[20]  M. Vettore,et al.  Kidney, splanchnic, and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics. , 1996, The Journal of clinical investigation.

[21]  R. Wolfe,et al.  TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. , 1996, The American journal of physiology.

[22]  S. Downie,et al.  Correction of acidosis in CAPD decreases whole body protein degradation. , 1996, Kidney international.

[23]  B. Beaufrère,et al.  Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Mitch,et al.  The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. , 1996, The Journal of clinical investigation.

[25]  W. Mitch,et al.  Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. , 1996, Kidney international.

[26]  J. Wang,et al.  Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. , 1996, The Journal of clinical investigation.

[27]  W. Mitch,et al.  Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. , 1995, The American journal of physiology.

[28]  V. Young,et al.  Long-term adaptive responses to dietary protein restriction in chronic renal failure. , 1995, The American journal of physiology.

[29]  W. Mitch,et al.  Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. , 1994, The American journal of physiology.

[30]  G. Deferrari,et al.  Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. , 1994, Kidney international.

[31]  A. Goldberg,et al.  Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. , 1994, The Journal of clinical investigation.

[32]  W. Mitch,et al.  Metabolic acidosis and uremic toxicity: protein and amino acid metabolism. , 1994, Seminars in nephrology.

[33]  B. Pereira,et al.  Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients , 1994 .

[34]  C. Slaughter,et al.  Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. , 1994, The Journal of biological chemistry.

[35]  C. Scrimgeour,et al.  Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. , 1993, The American journal of physiology.

[36]  A. Goldberg,et al.  Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. , 1993, The American journal of physiology.

[37]  B. Lindholm,et al.  Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? , 1993, Kidney international. Supplement.

[38]  J. Walls,et al.  Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. , 1991, Kidney international.

[39]  J. Walls,et al.  Skeletal muscle degradation and nitrogen wasting in rats with chronic metabolic acidosis. , 1991, Clinical science.

[40]  R. Hoerr,et al.  Adaptation to low-protein diets in renal failure: leucine turnover and nitrogen balance. , 1990, Journal of the American Society of Nephrology : JASN.

[41]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  M. Buse,et al.  Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. , 1990, The Journal of clinical investigation.

[43]  J. Pomposelli,et al.  Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. , 1989, The Journal of clinical investigation.

[44]  W. Mitch,et al.  Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats. , 1987, Kidney international.

[45]  R. Griffiths,et al.  Conchotome and needle percutaneous biopsy of skeletal muscle. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[46]  W. Mitch,et al.  Branched-chain amino acid metabolism in rat muscle: abnormal regulation in acidosis. , 1987, The American journal of physiology.

[47]  W. Mitch,et al.  Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. , 1987, The Journal of clinical investigation.

[48]  M. Mcgeown,et al.  The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. , 1984, The American journal of clinical nutrition.

[49]  R. DeFronzo,et al.  Insulin resistance in uremia. , 1981, The Journal of clinical investigation.

[50]  R. DeFronzo,et al.  Glucose intolerance following chronic metabolic acidosis in man. , 1979, The American journal of physiology.

[51]  R. Morris,et al.  Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. , 1978, The Journal of clinical investigation.

[52]  D. Lyon,et al.  THE ALKALINE TREATMENT OF CHRONIC NEPHRITIS. , 1931 .